导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 30.25% | 145/4773 |
| 近一周 | 2.22% | 138/5465 |
| 近一月 | -6.42% | 4175/5421 |
| 近一季 | -11.17% | 3879/5231 |
| 近半年 | 22.95% | 149/4920 |
| 近一年 | 33.50% | 182/4394 |
| 近两年 | 194.59% | 97/2954 |
| 近三年 | 132.21% | 55/2253 |
| 成立以来 | 78.20% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.31% 4091/4961 |
107.85% 57/5312 |
- - |
- - |
| 2025 | 40.38% 778/4813 |
0.56% 1817/3635 |
-0.36% 2902/4076 |
53.58% 247/4524 |
-8.78% 3957/4813 |
| 2024 | 31.52% 96/3463 |
-9.40% 2282/2808 |
0.60% 571/3014 |
18.71% 952/3129 |
21.56% 28/3463 |
| 2023 | -6.50% 847/2656 |
14.41% 243/2280 |
-8.14% 1965/2385 |
-9.75% 1890/2515 |
-1.42% 325/2655 |
| 2022 | -38.85% 1766/2207 |
-21.86% 1662/1919 |
0.43% 1550/2016 |
-21.52% 1905/2113 |
-0.70% 1638/2208 |
| 2021 | 34.57% 49/1822 |
-8.12% 1077/1255 |
41.49% 17/1330 |
-2.87% 598/1466 |
6.58% 210/1822 |
| 2020 | - - |
- - |
30.37% 57/1067 |
-1.40% 1065/1164 |
6.57% 753/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 广发国证半导体芯片ETF VS. 长安沪深300非周期A(740101) |